drugset / Trial / NCT06106906
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
Phase 1/2
Recruiting
15 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Guangzhou Bio-gene Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to explore the safety and efficacy of CD19 CAR-T in active systemic lupus erythematosus.
Timeline
- Start
- 2024-06-19
- Primary completion
- 2025-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19-CAR T cell | Cell therapy | — | Intravenous |